Wall Street analysts expect HealthStream, Inc. (NASDAQ:HSTM) to announce $62.20 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for HealthStream’s earnings. The lowest sales estimate is $61.70 million and the highest is $62.69 million. HealthStream reported sales of $59.93 million in the same quarter last year, which would suggest a positive year over year growth rate of 3.8%. The business is scheduled to issue its next earnings results after the market closes on Monday, October 21st.
According to Zacks, analysts expect that HealthStream will report full year sales of $253.89 million for the current financial year, with estimates ranging from $253.20 million to $254.57 million. For the next year, analysts expect that the company will post sales of $253.69 million, with estimates ranging from $253.37 million to $254.00 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research analysts that follow HealthStream.
HealthStream (NASDAQ:HSTM) last posted its quarterly earnings data on Monday, July 22nd. The technology company reported $0.07 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.07. HealthStream had a net margin of 5.71% and a return on equity of 4.22%. The company had revenue of $63.78 million for the quarter, compared to the consensus estimate of $63.12 million. During the same period last year, the company earned $0.11 earnings per share. The firm’s revenue was up 11.9% compared to the same quarter last year.
A number of analysts have recently issued reports on HSTM shares. ValuEngine upgraded shares of HealthStream from a “hold” rating to a “buy” rating in a report on Tuesday, July 9th. Barrington Research reiterated a “market perform” rating on shares of HealthStream in a report on Thursday, July 25th. BidaskClub downgraded shares of HealthStream from a “buy” rating to a “hold” rating in a report on Wednesday, August 28th. Finally, Zacks Investment Research downgraded shares of HealthStream from a “buy” rating to a “hold” rating in a report on Tuesday, October 1st. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $28.00.
Shares of NASDAQ HSTM traded up $0.17 during midday trading on Wednesday, reaching $26.33. The company’s stock had a trading volume of 71,832 shares, compared to its average volume of 125,227. The company has a current ratio of 2.18, a quick ratio of 2.18 and a debt-to-equity ratio of 0.10. HealthStream has a fifty-two week low of $23.06 and a fifty-two week high of $30.00. The stock has a market capitalization of $854.89 million, a price-to-earnings ratio of 61.23, a PEG ratio of 5.77 and a beta of 0.69. The stock has a 50 day simple moving average of $26.06 and a 200-day simple moving average of $26.46.
In other HealthStream news, Director Jeffrey L. Mclaren sold 5,000 shares of the company’s stock in a transaction on Monday, August 12th. The shares were sold at an average price of $28.58, for a total value of $142,900.00. Following the transaction, the director now directly owns 14,193 shares in the company, valued at $405,635.94. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 20.40% of the stock is currently owned by insiders.
Several institutional investors have recently made changes to their positions in the company. First Light Asset Management LLC lifted its position in HealthStream by 0.4% during the second quarter. First Light Asset Management LLC now owns 90,924 shares of the technology company’s stock worth $2,351,000 after purchasing an additional 386 shares during the period. Resources Investment Advisors LLC. raised its stake in HealthStream by 13.0% during the second quarter. Resources Investment Advisors LLC. now owns 3,900 shares of the technology company’s stock worth $101,000 after acquiring an additional 450 shares in the last quarter. Royal Bank of Canada raised its stake in HealthStream by 6.7% during the second quarter. Royal Bank of Canada now owns 7,424 shares of the technology company’s stock worth $192,000 after acquiring an additional 464 shares in the last quarter. Parametric Portfolio Associates LLC raised its stake in HealthStream by 1.4% during the second quarter. Parametric Portfolio Associates LLC now owns 54,303 shares of the technology company’s stock worth $1,404,000 after acquiring an additional 774 shares in the last quarter. Finally, Swiss National Bank raised its stake in HealthStream by 1.9% during the second quarter. Swiss National Bank now owns 48,100 shares of the technology company’s stock worth $1,244,000 after acquiring an additional 900 shares in the last quarter. 72.72% of the stock is owned by institutional investors.
HealthStream, Inc provides workforce and provider solutions for healthcare organizations in the United States. It operates through two segments, Workforce Solutions and Provider Solutions. The company offers workforce solutions, including software-as-a-service (SaaS) based services and subscription-based solutions to meet the training, certification, assessment, development, clinical development, talent management, performance appraisal, and other needs, as well as training, implementation, and account management services for the healthcare community.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.